Fig. 3.
Fig. 3. MHC class II molecule acquisition is marked enhanced by T-cell activation. / DO11.10 CD4+ T cells were cocultured overnight with bone marrow–derived BALB/c DCs or CBA DCs either without peptide, with 10 μg/mL OVA323-339 peptide, or 1 μg/mL soluble anti-CD3. Cells were then harvested and stained with PE-conjugated anti–H2-Ad or anti–H2-Ak, and FITC-conjugated anti-CD4 (bold lines). The levels of H2-Ad and H2-Ak on DO11.10 CD4+ cells were analyzed by flow cytometry. Only the CD4+ population was gated for analysis. (DO11.10 CD4+ T cells in medium control [shaded areas] for H2-Ad staining: MFI = 10.64; % in M1 gate = 1.66%; H2-Ak staining: MFI = 18.76; % in M1 gate = 3.22%.)

MHC class II molecule acquisition is marked enhanced by T-cell activation.

DO11.10 CD4+ T cells were cocultured overnight with bone marrow–derived BALB/c DCs or CBA DCs either without peptide, with 10 μg/mL OVA323-339 peptide, or 1 μg/mL soluble anti-CD3. Cells were then harvested and stained with PE-conjugated anti–H2-Ad or anti–H2-Ak, and FITC-conjugated anti-CD4 (bold lines). The levels of H2-Ad and H2-Ak on DO11.10 CD4+ cells were analyzed by flow cytometry. Only the CD4+ population was gated for analysis. (DO11.10 CD4+ T cells in medium control [shaded areas] for H2-Ad staining: MFI = 10.64; % in M1 gate = 1.66%; H2-Ak staining: MFI = 18.76; % in M1 gate = 3.22%.)

Close Modal

or Create an Account

Close Modal
Close Modal